Levaquin CAP Resistance Promotions Should Encourage "Prudent Use" - FDA
Executive Summary
FDA is requesting that Ortho-McNeil promote Levaquin responsibly following the Feb. 2 approval of the oral and injectable quinolone for treatment of penicillin-resistant S. pneumoniae in patients with community-acquired pneumonia.